SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-027086
Filing Date
2019-05-06
Accepted
2019-05-06 12:55:19
Documents
2
Period of Report
2019-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-9405_18k.htm 8-K 22546
2 EX-99.1 a19-9405_1ex99d1.htm EX-99.1 7512
  Complete submission text file 0001104659-19-027086.txt   31167
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 19798721
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1